HKSE
# |
Name |
Revenue |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 452.25 B
|
Dec. 31, 2023 | USD 0.55 | 0.68% |
|
China |
|
2 |
USD 424.10 B
|
Dec. 31, 2023 | USD 0.81 | 0.62% |
|
China |
|
3 |
USD 177.96 B
|
Dec. 31, 2023 | USD 0.47 | 2.48% |
|
China |
|
4 |
USD 160.29 B
|
Dec. 31, 2023 | USD 0.69 | 1.86% |
|
China |
|
5 |
USD 152.77 B
|
Dec. 31, 2023 | USD 17.45 | 5.32% |
|
China |
|
6 |
USD 142.16 B
|
Dec. 31, 2023 | USD 9.54 | 0.18% |
|
Hong Kong |
|
7 |
USD 130.30 B
|
March 31, 2024 | USD 10.26 | 2.34% |
|
China |
|
8 |
USD 112.97 B
|
Dec. 31, 2023 | USD 5.31 | 1.07% |
|
China |
|
9 |
USD 106.43 B
|
Dec. 31, 2023 | USD 0.65 | 2.18% |
|
China |
|
10 |
USD 103.50 B
|
Dec. 31, 2023 | USD 1.70 | 2.13% |
|
China |
|
11 |
USD 96.32 B
|
Dec. 31, 2023 | USD 1.08 | 1.06% |
|
Hong Kong |
|
12 |
USD 92.53 B
|
Dec. 31, 2023 | USD 0.63 | 0.60% |
|
China |
|
13 |
USD 89.28 B
|
Dec. 31, 2023 | USD 0.20 | 3.35% |
|
China |
|
14 |
USD 87.66 B
|
Dec. 31, 2023 | USD 0.77 | 1.51% |
|
China |
|
15 |
USD 85.78 B
|
Dec. 31, 2023 | USD 48.14 | 2.44% |
|
China |
|
16 |
USD 84.84 B
|
Dec. 31, 2023 | USD 32.99 | 3.11% |
|
China |
|
17 |
USD 84.03 B
|
Dec. 31, 2023 | USD 2.59 | 1.33% |
|
China |
|
18 |
USD 78.84 B
|
Dec. 31, 2023 | USD 0.54 | 0.46% |
|
China |
|
19 |
USD 73.51 B
|
Dec. 31, 2023 | USD 1.64 | 0.13% |
|
China |
|
20 |
USD 73.00 B
|
Dec. 31, 2023 | USD 0.49 | 0.51% |
|
China |
|
21 |
USD 71.53 B
|
Dec. 31, 2023 | USD 0.60 | -1.08% |
|
Hong Kong |
|
22 |
USD 70.67 B
|
Dec. 31, 2023 | USD 0.47 | 2.19% |
|
China |
|
23 |
USD 65.60 B
|
Dec. 31, 2023 | USD 0.64 | 2.88% |
|
China |
|
24 |
USD 62.37 B
|
Dec. 31, 2023 | USD 0.92 | 2.25% |
|
China |
|
25 |
USD 62.00 B
|
Dec. 31, 2023 | USD 1.54 | 1.84% |
|
China |
|
26 |
USD 58.68 B
|
Dec. 31, 2023 | USD 2.50 | 1.22% |
|
Hong Kong |
|
27 |
USD 57.19 B
|
Dec. 31, 2023 | USD 0.12 | 3.27% |
|
China |
|
28 |
USD 56.86 B
|
March 31, 2024 | USD 1.19 | 0.08% |
|
Hong Kong |
|
29 |
USD 52.48 B
|
Dec. 31, 2023 | USD 0.92 | 0.40% |
|
Hong Kong |
|
30 |
USD 48.32 B
|
Dec. 31, 2023 | USD 3.96 | 1.29% |
|
China |
|
31 |
USD 45.68 B
|
Dec. 31, 2023 | USD 2.88 | 2.72% |
|
China |
|
32 |
USD 44.61 B
|
Dec. 31, 2023 | USD 0.57 | 0.43% |
|
China |
|
33 |
USD 41.95 B
|
Dec. 31, 2023 | USD 5.12 | 4.29% |
|
China |
|
34 |
USD 41.33 B
|
Dec. 31, 2023 | USD 1.97 | 0.37% |
|
China |
|
35 |
USD 38.98 B
|
Dec. 31, 2023 | USD 18.52 | 5.00% |
|
China |
|
36 |
USD 38.17 B
|
Dec. 31, 2023 | USD 4.33 | 2.87% |
|
China |
|
37 |
USD 36.82 B
|
Dec. 31, 2023 | USD 3.23 | 2.42% |
|
China |
|
38 |
USD 36.66 B
|
Dec. 31, 2023 | USD 1.58 | 1.46% |
|
China |
|
39 |
USD 35.83 B
|
Dec. 31, 2023 | USD 0.51 | 2.04% |
|
China |
|
40 |
USD 35.37 B
|
Dec. 31, 2023 | USD 2.83 | 0.20% |
|
Hong Kong |
|
41 |
USD 35.28 B
|
Dec. 31, 2023 | USD 5.11 | -0.02% |
|
Hong Kong |
|
42 |
USD 34.62 B
|
Dec. 31, 2023 | USD 0.67 | 1.53% |
|
Hong Kong |
|
43 |
USD 33.00 B
|
Dec. 31, 2023 | USD 0.62 | 2.96% |
|
China |
|
44 |
USD 31.70 B
|
Dec. 31, 2023 | USD 0.60 | 0.41% |
|
China |
|
45 |
USD 30.14 B
|
Dec. 31, 2023 | USD 1.72 | 5.17% |
|
China |
|
46 |
USD 29.61 B
|
Dec. 31, 2023 | USD 0.44 | 2.07% |
|
China |
|
47 |
USD 28.53 B
|
Dec. 31, 2023 | USD 1.58 | 1.63% |
|
Hong Kong |
|
48 |
USD 28.26 B
|
Dec. 31, 2023 | USD 0.78 | 0.14% |
|
China |
|
49 |
USD 27.92 B
|
Dec. 31, 2023 | USD 0.53 | 1.44% |
|
China |
|
50 |
USD 27.88 B
|
Dec. 31, 2023 | USD 0.28 | 2.32% |
|
China |
The company on the HKSE with the highest Revenue is China Petroleum & Chemical Corporation (HKSE: 0386.HK) at USD 452.25 B.
The company on the HKSE with the lowest Revenue is HighTide Therapeutics Inc (HKSE: 2511.HK) at USD 0.00.
The top 10 companies on the HKSE by Revenue are China Petroleum & Chemical Corporation, PetroChina Company Limited, China Railway Group Limited, China Railway Construction Corporation Limited, JD.com, Inc., China Mobile Limited, Alibaba Group Holding Limited, Ping An Insurance (Group) Company of China, Ltd., China Communications Construction Company Limited and China Life Insurance Company Limited.
The bottom 10 companies on the HKSE by Revenue are HighTide Therapeutics Inc, Genor Biopharma Holdings Limited, Shanghai Bio-heart Biological Technology Co., Ltd., ImmuneOnco Biopharmaceuticals (Shanghai) Inc., SinoMab BioScience Limited, Sirnaomics Ltd., Bingo Group Holdings Limited, Wuhan YZY Biopharma Co Ltd, Zhaoke Ophthalmology Limited and Abbisko Cayman Limited.